Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Nanoparticles in Melanoma

Author(s): M.A. Berciano-Guerrero, A. Montesa-Pino, G. Castaneda-Penalvo, L. Munoz-Fernandez and J. Rodriguez-Flores

Volume 21, Issue 32, 2014

Page: [3701 - 3716] Pages: 16

DOI: 10.2174/0929867321666140716092512

Price: $65


Malignant melanoma is one of the most common causes of cancer and cancer deaths in young people. Until few years ago, scarce drugs have proven efficacy in metastatic setting. However, in the recent years, the treatment of metastatic malignant melanoma has undergone the incorporation of effective treatment such as immunotherapy, the use of tyrosine kinase inhibitors and the emergence of other cytostatic compounds, like the nanoparticles. This review aims to propose a standardization to classify the different types of nanoparticles, according to chemical aspects, and update the clinical research with nanoparticles and their use in melanoma field.

Keywords: Cancer, classification, melanoma, nab-paclitaxel, nanoparticles.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy